The phenotype of the pediatric patient with Cushing syndrome but without obesity
European Journal of Endocrinology · 2024
DOI: 10.1093/ejendo/lvae114 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Cameron Padilla und 2 weiteren Autor:innen. Beteiligte Einrichtung: Unit on Hypothalamic and Pituitary Disorders, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Insti…. Hauptthemen laut MEDLINE: Cushing Syndrome, Phenotype. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural Research Program, Eunice Kennedy Shriver National Institute of Child Health & Human Development, NIH HHS.
Abstract (Originalsprache)
Objective
Cushing syndrome (CS) often presents with obesity that is not as severe in children as it is in adults. The role of obesity in the severity of metabolic syndrome in children with CS has not been studied. This study evaluates whether pediatric patients with CS have obesity-specific differences in their demographic, biochemical, and presenting findings.
Design
Cohort study. Participants and Methods We analyzed 273 patients with young onset of CS at ≤18 years old and who were classified as patients with or without obesity based on their BMI z scores.
Results
Patients without obesity (n = 84, 31%) were more frequently females with an older age of onset compared with patients with obesity (n = 189, 69%). Consistent with their older age, patients without obesity were also more likely to have advanced Tanner stages. Patients with and without obesity had a similar duration of disease, but patients with obesity showed higher markers of hypercortisolemia (urinary free cortisol, UFC). A higher prevalence of hypertension and insulin resistance was seen in patients with obesity than those without obesity, adjusting for UFC (P < .05 for all comparisons). While fatty liver disease was not statistically different among the entire cohort, elevated alanine transaminase and metabolic dysfunction–associated steatotic liver disease scores were more common in ACTH-dependent CS patients with obesity (P < .05).
Conclusions
Weight gain appears to mediate some but not all the cortisol-associated complications in pediatric CS. Therefore, obesity may be a modifiable risk factor among these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit on Hypothalamic and Pituitary Disorders, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health, Bethesda, MD, United States.
- Human Genetics and Precision Medicine, IMBB, FORTH, Heraklion, Greece.
- Medical Genetics, H. Dunant Hospital, Athens, Greece.
- ASTREA Health, Athens, Greece.
ORCID-Profile: Cameron Padilla, Christina Tatsi
Förderung
- Intramural Research Program
- Eunice Kennedy Shriver National Institute of Child Health & Human Development
- NIH HHS
- National Institutes of Health
Zitieren
APA
Padilla, C., Stratakis, C. A., & Tatsi, C. (2024). The phenotype of the pediatric patient with Cushing syndrome but without obesity. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae114
Vancouver
Padilla C, Stratakis CA, Tatsi C. The phenotype of the pediatric patient with Cushing syndrome but without obesity. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae114
BibTeX
@article{Padilla2024,
author = {Padilla, Cameron and Stratakis, Constantine A and Tatsi, Christina},
title = {The phenotype of the pediatric patient with Cushing syndrome but without obesity},
journal = {European Journal of Endocrinology},
year = {2024},
doi = {10.1093/ejendo/lvae114}
}
EUVIMED